Announcements Trials
Browse Landscape

Status

Recruiting 20Active not recruiting 10Completed 4Not yet recruiting 3Terminated 1Enrolling by invitation 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Recurrence 3Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 2Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1HER2-positive Breast Cancer 1Glioma 1EGFRm Advanced Non-Small Cell Lung Cancer 1Cholangiocarcinoma 1Carcinoma, Basal Cell 1Advanced Cancers and FGFR Genetic Alterations 1

Interventions

niraparib 1Prednisone 1Prednisolone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Approved for marketing × Metastatic Castration-resistant Prostate Cancer × 1 year × Clear all
NCT05401214 2025-06-13

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Janssen Research & Development, LLC

Approved for marketing
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡